Determining Predictors of Early Response to Exenatide in Patients with Type 2 Diabetes Mellitus

Exenatide is a GLP-1 analogue used in the management of T2DM yet within a subset of patients fails due to adverse side effects or from failure to attain the end goal. This retrospective observational study aimed to determine whether we could predict response to exenatide in patients with T2DM. 112 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad, Ouyang, Jing, Perkins, Karen, Nair, Sunil, Joseph, Franklin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320857/
https://www.ncbi.nlm.nih.gov/pubmed/25688374
http://dx.doi.org/10.1155/2015/162718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320857/
https://www.ncbi.nlm.nih.gov/pubmed/25688374
http://dx.doi.org/10.1155/2015/162718

Ejemplares similares